Due to maintenance work, this service will be unavailable from
Mon Nov 11 17:30 until
Tue Nov 12 09:00
CET.
Apologies for the inconvenience.
Cellosaurus RCi002-B (CVCL_9S44)
Cell line name | RCi002-B |
---|---|
Synonyms | RCi93; FP5C-16; EM5-16 |
Accession | CVCL_9S44 |
Resource Identification Initiative | To cite this cell line use: RCi002-B (RRID:CVCL_9S44) |
Comments | From: Pfizer, Inc.; New York; USA. From: Roslin Cells, Ltd; Roslin; United Kingdom. Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. |
Sequence variations |
|
Disease | Erythromelalgia (NCIt: C34593) Primary erythromelalgia (ORDO: Orphanet_90026) |
Species of origin | Homo sapiens (Human) (NCBI Taxonomy: 9606) |
Originate from same individual | CVCL_9S43 ! RCi002-A |
Sex of cell | Female |
Age at sampling | <2Y |
Category | Induced pluripotent stem cell |
Publications | PubMed=27099175; DOI=10.1126/scitranslmed.aad7653 |
Cross-references | |
Cell line collections (Providers) | EBiSC; RCi002-B
ECACC; 66540050 - Discontinued |
Cell line databases/resources | hPSCreg; RCi002-B
SKIP; SKIP002475 |
Biological sample resources | BioSamples; SAMEA3106075 |
Encyclopedic resources | Wikidata; Q54949501 |
Entry history | |
Entry creation | 23-Feb-2016 |
Last entry update | 30-Jan-2024 |
Version number | 14 |